יום רביעי, ו׳ אלול תשפ״וWednesday, August 19, 2026
Follow Us
This study conclusively demonstrates the long-speculated relationship between aging, gene regulation, and somatic damage.
By Ken Stephens
"This is important news for patients with chronic kidney disease, who hopefully will benefit from these discoveries in the coming years."
The Novartis dug company is in advanced talks to buy up Israeli-based stem cell treatments developer Gamida-Cell for $600 million, sources told the Globes business newspaper. Slightly more than half of Gamida-Cell is owned by Clal Biotechnology and Elbit Medical Technologies, a subsidiary of Elbit Imaging. Gamida-Cell has been considering offering an IPO on Wall […]
August 14, 2026 
